Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
06/10/2026 15:24
BUZZ-Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal ** Personalis PSNL.O shares fall ~2% to $16.12
** BTIG downgrades cancer test maker to "neutral" from "buy"
** Brokerage says Tempus AI TEM.O to complete PSNL acquisition in coming months; sees no higher offer "despite competitive bidding process"
** Tempus AI agreed to acquire Personalis in July 2026 in a deal valued at about $1.5 bln
** 1 of 5 brokerages rate the stock "strong buy", 4 "hold", median PT: $16.25 - data compiled by LSEG
** Including session's moves, stock has risen 104.40% YTD
(Reporting by Miraanta Lowrance in Bengaluru)
Recent news on Personalis
See all newsBrief: Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary